Therapeutic Area Market Research

Total Records (28)
Show

Drug-Device Combination Products Market By Product (Drug Eluting Stents, Infusion Pumps, Photosensitizers, Orthopedic Combination Products, Wound Care Combination Products, Inhalers, Transdermal Patches, Others), By Application (Cardiovascular, Diabetes, Cancer Treatment, Respiratory Diseases, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Others) - Growth, Share, Opportunities & Competitive Analysis, 2024 - 2032

The drug-device combination products market is a rapidly growing sector within the healthcare industry that combines the benefits of pharmaceuticals and medical devices. These products consist of a combination of drugs and medical devices, which are designed to work together to deliver therapeutic treatments and enhance patient outcomes. The market revenue for drug-device combination products has been steadily increasing in recent years, driven by factors such as the rising prevalence of chronic diseases, technological advancements, and the growing demand for personalized medicine.

4500
24 Jul, 2023

Sex Reassignment Surgery Market By Male To Female (Facial, Breast, Genital), By Female To Male (Facial, Chest, Genital), By End-user (Hospitals, Clinics) - Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

The market for sex reassignment surgery is projected to develop at a CAGR of 11.5% during the forecast period of 2024 to 2032. Incidences of gender dysphoria are on the rise, and more people are opting for gender confirmation operations, which is projected to drive growth throughout the projection period. 78% of transgender males, according to a study conducted by Cedars Sinai in June 2020, experienced gender dysphoria before the age of 7.

4500
13 Apr, 2023

Porokeratosis Treatment Market By Type, By Diagnosis, By Treatment, By End-user- Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

The market for Porokeratosis Treatment is projected to expand at a CAGR of 7% during the forecast period of 2024 to 2032. Numerous factors, including an increase in renal transplant cases, improved reimbursement policies in developed nations, an increase in research funding, and intensifying competition among market participants, continue to contribute to the expansion of the global market.

4500
10 Apr, 2023

Dental Gypsum Market By Product (Impression Plaster (Type I), Modelling plaster (Type II), Stone Hard Plaster (Type III), Improved stone Plaster (Type IV), High-strength plaster (Type V)), By End-user (Hospitals, Dental Clinics, Academic & Research Institutes) - Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

The global market for dental gypsum is anticipated to grow at a CAGR of 5% during the forecast period of 2024 to 2032. This is attributable to the rise in dental tourism, demand for cosmetic dentistry, and oral health awareness. The adoption of digital dentistry technologies, such as CAD/CAM systems and 3D printing, is anticipated to contribute to industry growth.

4500
17 Mar, 2023

Acute Respiratory Distress Syndrome Devices Market By Type (Therapeutic Devices, Diagnostic & Monitoring Devices), By End-user (Hospitals, Specialty Centers, Others), By Injury (Brain, Lung), By Severity (Mild, Moderate, Severe) - Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

The acute respiratory distress syndrome (ARDS) devices market is expected to grow at a CAGR of 7.5% during the forecast period of 2024 to 2032. Acute respiratory distress syndrome (ARDS) is a severe lung condition that can be caused by a variety of underlying conditions, including sepsis, pneumonia, and trauma. It is marked by inflammation and fluid accumulation in the lungs, which can lead to breathing difficulties and low blood oxygen levels.

4500
15 Feb, 2023

Acute Lung Injury Treatment Market By Injury Type (Direct Injury, Indirect Injury), By Theraphy (Medication, Devices), By End-user (Hospitals, Specialty Centres, Others) - Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

The market for Acute Lung Injury is expected to rise at a CAGR of 3.5% during the forecast period of 2024 to 2032. Acute Lung Injury (ALI) is a severe medical condition in which lung tissues become inflamed and damaged, causing difficulty breathing and low blood oxygen levels. Infections, chemical exposure, and trauma are significant risk factors for ALI.

4500
14 Feb, 2023

Absorbable Antibacterial Envelope Market By Application (Cardiac Resynchronization Therapy Defibrillators, Implantable Cardioverter Defibrillators, Cardiac Resynchronization Therapy Pacemakers), By End-user (Hospitals, Ambulatory Surgical Centers) - Growth, Share, Opportunities & Competitive Analysis, 2024 - 2032

Despite advances in treatment, the high morbidity and death rate of heart failure is driving the global absorbable antibacterial envelope market. Mortality in individuals with heart failure is not only caused by hemodynamic failure; ventricular arrhythmias might also be to blame. In the coming years, the use of implantable cardioverter defibrillators (ICDs) to reduce arrhythmic sudden fatalities is anticipated to boost the market. Moreover, cardiac resynchronization therapy (CRT) is another promising treatment option for heart failure patients.

4500
10 Jan, 2023

Acquired von Willebrand Disease (AvWD) Treatment Market By Treatment Type (Desmopressin, Replacement Therapy, Clot-stabilizing Medications/anti-fibrinolytic medications, Others), By Route of Drug Administration (Oral, Injection, Others), By Healthcare Settings (Hospitals, Clinics, Others) – Growth, Future Prospects and Competitive Analysis, 2024 - 2032

Acquired von Willebrand syndrome is a highly heterogeneous bleeding disorder, usually displays mild to moderate hemorrhagic symptoms that may at times be severe too. Many a time the severity increases post-surgery. AvWD is considered as a rare disorder, however, the actual prevalence is not as rare.

4500
18 Jul, 2023

Adhesive Bandages Market By Adhesive Bandages (Flexible Fabric Bandage, Cohesive Fixation Bandage), By Material (Woven Fabric, Plastic, Foam, Tricot) - Growth, Future Prospects & Competitive Analysis, 2018 - 2026

Adhesive bandages market accounted for a market value of US$ 1,895.0 Mn in 2017 and projected to grow at a CAGR of 4.8% during the forecast period from 2018 to 2026. The key factors responsible for growth of adhesive bandages globally is the rising awareness related to the acute wound protection in developing countries, and increasing awareness programmes for diabetes patients to treat acute wound efficiently with adhesive bandages.

4325
28 Jan, 2019

Acute Care Needleless Connectors Market By Mechanism (Positive Fluid Displacement, Negative Fluid Displacement, Neutral Fluid Displacement), By Connector (Simple Needleless Connectors, Complex Needleless Connectors), By End-User (Hospitals, Clinics, Ambulatory Centers) - Growth, Future Prospects And Competitive Analysis, 2018 – 2026

Acute care needleless connectors market accounted for a market value of US$ 648.8 Mn in 2017 and projected to grow at a CAGR of 5.1% during the forecast period from 2018 to 2026. The key factors responsible for growth of acute care needleless connectors market are the rising prevalence of needlestick injuries, high awareness related to the advantages of acute care needleless connectors in healthcare personnel, and increasing number of ambulatory centres. According to the World Health Organization (WHO) 1 in 10 healthcare personnel globally sustain a needlestick injury every year.

4325
15 Jan, 2019
Filter

Key Sectors

The therapeutic Area Market refers to a certain area of diseases or ailments for which there are established medical treatments or prospective remedies in development. It is a method of classifying pharmaceuticals without regard to the type of therapy, mode of action, or manufacturer, but rather by the ailment it treats. Oncology expenditures are predicted to exceed US $300 billion by 2025. With estimated expenditures of roughly US $190 billion, immunology is expected to rank second.
 
According to the January 2021 publication "The Longitudinal Ageing Study in India (LASI)," around 75 million Indians aged 60 and older suffer from a chronic condition. Around 45 million suffer from cardiovascular disease and hypertension, while 20 million have diabetes. Consequently, the high prevalence of chronic diseases in the country will increase the demand for cost-effective therapies, such as digital therapeutic devices, and drive the market under study. There has been an increase in the therapeutic use of technology for medical ailments. People in developed markets are becoming increasingly aware of the advanced medical treatments available. The Organization for Economic Co-operation and Development said in July 2019 that healthcare spending as a percentage of GDP climbed significantly in 2020, as the economic situation deteriorated and health spending soared in several OECD nations. In 2020, health expenditures per capita for a group of 16 nations are projected to increase by approximately 4.9% on average. So, the choice has turned toward enhanced services in the medical industry, including the rising demand for therapeutic gadget developments. Product approval is another aspect contributing to the expansion of the industry. In December 2020, for instance, the United States Food and Drug Administration granted San Francisco and London-based Mahana Therapeutics a De Novo marketing authorization for a product called Parallel, which according to company literature is an 8-week cognitive behavioral therapy program for people with irritable bowel syndrome. Such approvals will stimulate market expansion.
 
The increasing prevalence of chronic illnesses contributes to the segment's expansion. According to the International Diabetes Federation (IDF), roughly 536 million adults (20-79 years of age) had diabetes in 2021, and this number will increase to 783 million by 2045. In the majority of countries, the prevalence of type 2 diabetes is increasing, and 79% of adults with diabetes reside in low- and middle-income countries, where 1 in 5 persons over 65 have the disease. In the majority of countries, the prevalence of type 2 diabetes is increasing, and 79% of adults with diabetes reside in low- and middle-income countries, where 1 in 5 persons over 65 have the disease.
 
Acute Market Reports specializes in market research and consulting for therapeutic area markets. Our clients benefit from Acute Market Reports' futuristic research technique, which enables them to make timely, well-considered business decisions. We work with a wide range of industry participants to give cutting-edge strategic research solutions to our global clients.